GIKLY
Price
$7.04
Change
-$0.01 (-0.14%)
Updated
Jul 18 closing price
Capitalization
8.78B
2 days until earnings call
GLAXF
Price
$18.84
Change
+$0.17 (+0.91%)
Updated
Jul 25 closing price
Capitalization
103.73B
Interact to see
Advertisement

GIKLY vs GLAXF

Header iconGIKLY vs GLAXF Comparison
Open Charts GIKLY vs GLAXFBanner chart's image
Grifols Sa
Price$7.04
Change-$0.01 (-0.14%)
Volume$103
Capitalization8.78B
GSK
Price$18.84
Change+$0.17 (+0.91%)
Volume$196
Capitalization103.73B
GIKLY vs GLAXF Comparison Chart in %
Loading...
GIKLY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GLAXF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GIKLY vs. GLAXF commentary
Jul 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GIKLY is a Hold and GLAXF is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 28, 2025
Stock price -- (GIKLY: $7.04 vs. GLAXF: $18.84)
Brand notoriety: GIKLY and GLAXF are both not notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: GIKLY: 9% vs. GLAXF: 4%
Market capitalization -- GIKLY: $8.78B vs. GLAXF: $103.73B
GIKLY [@Pharmaceuticals: Major] is valued at $8.78B. GLAXF’s [@Pharmaceuticals: Major] market capitalization is $103.73B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $739.66B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $86.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GIKLY’s FA Score shows that 1 FA rating(s) are green whileGLAXF’s FA Score has 2 green FA rating(s).

  • GIKLY’s FA Score: 1 green, 4 red.
  • GLAXF’s FA Score: 2 green, 3 red.
According to our system of comparison, GLAXF is a better buy in the long-term than GIKLY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GIKLY’s TA Score shows that 2 TA indicator(s) are bullish while GLAXF’s TA Score has 4 bullish TA indicator(s).

  • GIKLY’s TA Score: 2 bullish, 3 bearish.
  • GLAXF’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, GIKLY is a better buy in the short-term than GLAXF.

Price Growth

GIKLY (@Pharmaceuticals: Major) experienced а 0.00% price change this week, while GLAXF (@Pharmaceuticals: Major) price change was +9.88% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was +3.43%. For the same industry, the average monthly price growth was +7.37%, and the average quarterly price growth was +13.00%.

Reported Earning Dates

GIKLY is expected to report earnings on Jul 29, 2025.

Industries' Descriptions

@Pharmaceuticals: Major (+3.43% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GLAXF($104B) has a higher market cap than GIKLY($8.79B). GIKLY has higher P/E ratio than GLAXF: GIKLY (75.19) vs GLAXF (17.36). GIKLY YTD gains are higher at: 49.787 vs. GLAXF (12.000). GLAXF has higher annual earnings (EBITDA): 10B vs. GIKLY (726M). GLAXF has more cash in the bank: 14B vs. GIKLY (557M). GIKLY has less debt than GLAXF: GIKLY (10.9B) vs GLAXF (33.3B). GLAXF has higher revenues than GIKLY: GLAXF (36.5B) vs GIKLY (6.46B).
GIKLYGLAXFGIKLY / GLAXF
Capitalization8.79B104B8%
EBITDA726M10B7%
Gain YTD49.78712.000415%
P/E Ratio75.1917.36433%
Revenue6.46B36.5B18%
Total Cash557M14B4%
Total Debt10.9B33.3B33%
FUNDAMENTALS RATINGS
GIKLY vs GLAXF: Fundamental Ratings
GIKLY
GLAXF
OUTLOOK RATING
1..100
5075
VALUATION
overvalued / fair valued / undervalued
1..100
21
Undervalued
8
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
8741
PRICE GROWTH RATING
1..100
3856
P/E GROWTH RATING
1..100
9325
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

GLAXF's Valuation (8) in the null industry is in the same range as GIKLY (21). This means that GLAXF’s stock grew similarly to GIKLY’s over the last 12 months.

GLAXF's Profit vs Risk Rating (100) in the null industry is in the same range as GIKLY (100). This means that GLAXF’s stock grew similarly to GIKLY’s over the last 12 months.

GLAXF's SMR Rating (41) in the null industry is somewhat better than the same rating for GIKLY (87). This means that GLAXF’s stock grew somewhat faster than GIKLY’s over the last 12 months.

GIKLY's Price Growth Rating (38) in the null industry is in the same range as GLAXF (56). This means that GIKLY’s stock grew similarly to GLAXF’s over the last 12 months.

GLAXF's P/E Growth Rating (25) in the null industry is significantly better than the same rating for GIKLY (93). This means that GLAXF’s stock grew significantly faster than GIKLY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
GIKLYGLAXF
RSI
ODDS (%)
N/A
Bullish Trend 3 days ago
62%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
69%
Bullish Trend 3 days ago
79%
Momentum
ODDS (%)
N/A
Bearish Trend 3 days ago
61%
MACD
ODDS (%)
Bearish Trend 3 days ago
56%
Bearish Trend 3 days ago
69%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
56%
Bullish Trend 3 days ago
65%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
57%
Bearish Trend 3 days ago
56%
Advances
ODDS (%)
N/A
Bullish Trend 3 days ago
65%
Declines
ODDS (%)
N/A
Bearish Trend 10 days ago
51%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
72%
Bullish Trend 3 days ago
72%
Aroon
ODDS (%)
Bullish Trend 3 days ago
62%
Bearish Trend 3 days ago
56%
View a ticker or compare two or three
Interact to see
Advertisement
GIKLY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GLAXF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
ACP5.950.07
+1.19%
abrdn Income Credit Strategies Fund
COWZ57.250.21
+0.37%
Pacer US Cash Cows 100 ETF
CPSD25.080.05
+0.21%
Calamos S&P 500 Str Alt Prt ETF-Dec
APRT39.880.08
+0.20%
AllianzIM US Large Cap Buffer10 Apr ETF
BKCH61.64-1.37
-2.18%
Global X Blockchain ETF

GIKLY and

Correlation & Price change

A.I.dvisor tells us that GIKLY and OPHLY have been poorly correlated (+10% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that GIKLY and OPHLY's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GIKLY
1D Price
Change %
GIKLY100%
N/A
OPHLY - GIKLY
10%
Poorly correlated
-0.82%
GLAXF - GIKLY
8%
Poorly correlated
+0.90%
NVSEF - GIKLY
7%
Poorly correlated
+0.22%
ORINY - GIKLY
4%
Poorly correlated
N/A
KYKOF - GIKLY
3%
Poorly correlated
N/A
More

GLAXF and

Correlation & Price change

A.I.dvisor tells us that GLAXF and OPHLY have been poorly correlated (+9% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that GLAXF and OPHLY's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GLAXF
1D Price
Change %
GLAXF100%
+0.90%
OPHLY - GLAXF
9%
Poorly correlated
-0.82%
GIKLY - GLAXF
8%
Poorly correlated
N/A
ORINY - GLAXF
3%
Poorly correlated
N/A
NVSEF - GLAXF
-0%
Poorly correlated
+0.22%
OPHLF - GLAXF
-2%
Poorly correlated
N/A
More